Olejárová, Marta
M Olejárová
VIAF ID: 85691098 (Personal)
Permalink: http://viaf.org/viaf/85691098
Preferred Forms
-
100 0 _
‡a
M Olejárová
-
100 1 _ ‡a Olejárová, Marta
-
100 1 _
‡a
Olejárová, Marta
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| Bechtěrevova nemoc : čtení o nemoci egyptských faraonů, Karla Čapka i vaší |
|
| Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries |
|
| Biologická léčba v revmatologii |
|
| Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A. |
|
| Farmakoterapie revmatických onemocnění |
|
| Lexikon revmatologie pro sestry |
|
| The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study |
|
| Revmatoidní artritida : čtení o nemoci severoamerických indiánů, slavných malířů i vaší |
|
| Revmatologie v obrazech |
|
| Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis. |
|
| Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. |
|
| Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study |
|
| Some principles of the development of a clinical database/national register of selected inflammatory rheumatic diseases in the Czech Republic |
|
| Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. |
|
